paper-with-me

Papers

Reinforcement Learning for Personalized Drug Discovery and Design for Complex Diseases: A Systems Pharmacology Perspective

2022-01-21 · Ryan K. Tan, Yang Liu, Lei Xie

Many multi-genic systemic diseases such as neurological disorders, inflammatory diseases, and the majority of cancers do not have effective treatments yet. Reinforcement learning powered systems pharmacology is a potentially effective approach to design personalized therapies for untreatable complex diseases. In this survey, state-of-the-art reinforcement learning methods and their latest applications to drug design are reviewed. The challenges on harnessing reinforcement learning for systems pharmacology and personalized medicine are discussed. Potential solutions to overcome the challenges are proposed. In spite of successful application of advanced reinforcement learning techniques to target-based drug discovery, new reinforcement learning strategies are needed to address systems pharmacology-oriented personalized de novo drug design.

📄 PDF Abstract BibTeX arXiv:2201.08894

Code (0)

등록된 구현이 없습니다.

Tasks

Drug DesignDrug Discoveryreinforcement-learningReinforcement LearningReinforcement Learning (RL)

Similar Papers 제목 키워드 기반

SynerGPT: In-Context Learning for Personalized Drug Synergy Prediction and Drug Design

2023-06-19 · Carl Edwards, Aakanksha Naik, Tushar Khot, Martin Burke 외

Predicting synergistic drug combinations can help accelerate discovery of cancer treatments, particularly therapies personalized to a patient's specific tumor via biopsied cells. In this paper, we propose a novel setting…

Drug DesignIn-Context LearningLanguage Modelling

ACEGEN: Reinforcement learning of generative chemical agents for drug discovery

2024-05-07 · Albert Bou, Morgan Thomas, Sebastian Dittert, Carles Navarro Ramírez 외

In recent years, reinforcement learning (RL) has emerged as a valuable tool in drug design, offering the potential to propose and optimize molecules with desired properties. However, striking a balance between capabiliti…

BenchmarkingDecision MakingDrug DesignDrug Discovery+3

3DMolFormer: A Dual-channel Framework for Structure-based Drug Discovery

2025-02-07 · Xiuyuan Hu, Guoqing Liu, Can Chen, Yang Zhao 외

Structure-based drug discovery, encompassing the tasks of protein-ligand docking and pocket-aware 3D drug design, represents a core challenge in drug discovery. However, no existing work can deal with both tasks to effec…

Drug DesignDrug Discovery

Applications of Large Models in Medicine

2025-02-24 · YunHe Su, Zhengyang Lu, Junhui Liu, Ke Pang 외

This paper explores the advancements and applications of large-scale models in the medical field, with a particular focus on Medical Large Models (MedLMs). These models, encompassing Large Language Models (LLMs), Vision …

DiagnosticDisease PredictionDrug DiscoveryKnowledge Graphs+1

Widely Used and Fast De Novo Drug Design by a Protein Sequence-Based Reinforcement Learning Model

2022-08-14 · YaQin Li, Lingli Li, Yongjin Xu, Yi Yu

De novo molecular design has facilitated the exploration of large chemical space to accelerate drug discovery. Structure-based de novo method can overcome the data scarcity of active ligands by incorporating drug-target …

Drug DesignDrug DiscoveryMolecular DockingReinforcement Learning (RL)